Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Meidakang Jiale Pharmaceutical is a Chinese pharmaceutical company and a core manufacturing subsidiary of the Meidakang Pharmaceutical Group. Based in Shifang, Sichuan Province, the company specializes in the development and production of both chemical drugs and Traditional Chinese Medicines (TCM). Its product portfolio is diverse, covering therapeutic areas such as cardiovascular health, respiratory diseases, and gastrointestinal disorders. The company operates modern, GMP-compliant facilities capable of producing various dosage forms, including tablets, capsules, and injections. Meidakang Jiale is notably recognized for its high-quality botanical extracts, particularly its Ginkgo biloba preparations used for circulatory support. As a key industrial entity in the region, it plays a significant role in the Meidakang Group's broader commercial strategy within the Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Meidakang Jiale Pharmaceutical.